ArticleOncotarget2017
Association of 15-hydroxyprostaglandin dehydrogenate and poor prognosis of obese breast cancer patients.
Ruxing Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it